Planning and guidance of complex percutaneous coronary interventions
3:30 AM America/New_York
The course will be largely based on live learning from live and recorder cases, linked to the meeting room with cutting edge technology which will facilitate discussion and interaction with all attendees. We will be delighted to bring live and recorded cases demonstrations from Hospital Clinico San Carlos, Madrid, Spain to showcase the planning of PCI procedures and, subsequently, the use of diagnostic and therapeutic tools during the intervention.
You will see that we are privileged to have a distinguished faculty in this two-day program; all of whom are engaged in cutting-edge research in the field of intravascular imaging and coronary physiology in addition to being expert PCI operators.
Welcome and Introductions, Complex PCI April 2021
Decision-making and problem solving in complex PCI: interactive case-based...
Evolving approaches to physiological guidance in complex PCI
Is the complexity of patients undergoing PCI shifting?
Complex anatomical subsets (I)
Can PCI be improved to treat angina in stable patients?
Close of day 1
Two-stent techniques in bifurcation stenosis PCI: setting the indication and...
Decision-making and problem solving in complex PCI: interactive case-based...
Live case from Hospital Clinico San Carlos, 13th April 2021
Complex anatomical subsets (II)
Ultra-low contrast PCI
Prof Javier Escaned is Head of Interventional Cardiology Section at Hospital Clinico San Carlos (Madrid, Spain). He trained as a cardiologist the United Kingdom before moving to the Thoraxcenter / Rotterdam (The Netherlands), where he obtained his PhD degree in 1994. A skilled interventionalist with over 30 years of experience, he regularly serves as live case operator and educationalist in global events like EuroPCR, TCT or the ESC Congress. He is author of over 400 PubMed indexed scientific articles (h-index 67) on topics that include complex PCI in multivessel disease (principal investigator of SYNTAX II study), left main and chronic total occlusions, and secondary revascularization. His track record in coronary physiology includes being investigator on pivotal FFR trials like DEFER (1998), collaborator with Justin Davies in the validation and clinical implementation of iFR (since 2010), and developer of new methods for the assessment of microvascular and non-obstructive coronary disease. Recent / ongoing trials as Co-PI include ADVISE, ADVISE II, DEFINE FLAIR and ABSORB II PHYSIOLOGY, being investigator also in ILUMIEN I and IV, COMBINE and other studies on coronary imaging. He is currently Deputy Editor for Interventional Cardiology of the European Heart Journal, as well as editor of two large textbooks: “Coronary Stenosis. Imaging, Structure and Physiology”, (co-editor Patrick Serruys) and “Physiological Assessment of Coronary Stenoses and the Microcirculation) (co-editor Justin Davies). Current or recent board positions in scientific societies include EuroPCR, EAPCI, EuroCTO and the ESC Working Group of Coronary Pathophysiology and Microcirculation. Some of his additional interests are philosophy, education and music.
Dr Justin Davies is a clinical academic and consultant interventional cardiologist at the National Heart and Lung Institute, Imperial College London. After training at Imperial College, he won a prestigious BHF research fellowship to study arterial haemodynamics. Since then he has continued to work on the development of mathematical algorithms to aid understanding of large artery physiology and to develop new tools to assess arterial disease. The holder of several patents, he has published widely in the field of hypertension, coronary and large artery physiology and is the winner of many national and international awards. He has several international collaborations, and is the developer of iFR and the co-principal investigator of the ADVISE studies, the DEFINE-FLAIR, ORBITA and DEFINE-PCI studies. Justin also has an interest in renal denervation, and has lead the first-in-man studies to evaluate the safety of this technique to patients with chronic systolic heart failure (REACH studies).
Dr Ashok Seth is Chairman of Fortis Escorts Heart Institute, New Delhi and Adjunct Professor of Cardiology at JN Medical College (Aligarh Muslim University) and National Board of Examinations. Dr Seth has led the field of Interventional Cardiology for last 30-years and has contributed extensively to the development, scientific progress and education in this field and pioneered numerous angioplasty techniques for India and Asia Pacific. Dr Seth has been awarded by the National Honour of Padma Shri in 2003, Padma Bhushan in 2015 and ‘B.C.Roy National Award’ for the most ‘Eminent Medical Person’ by the President of India in January 2017. He has also been awarded the National Honour of Republic of Spain “Crus Officer with Insignia Order of Isabella the Catholic”, Master Interventionalist (MSCAI) by the Society for Cardiovascular Angiography & Interventions (USA) in addition to 85 other national and international awards. Dr Seth has been honoured by Doctorates from six prestigious national universities – BHU, AMU, Jamia Millia Islamia, Amity, Shiv Nadar and Teerthankar Mahavir University. He has been conferred ‘Adjunct Professorship of Cardiology’ of J N Medical College, Aligarh Muslim University and the National Board of Examinations. He is Founder/Course Director of five major National & International Teaching Courses - India Live, India Valves, CHIP-CTO India, AICT-AsiaPCR and Imaging & Physiology Council of India. He is also Associate Director of TCT Scientific Sessions (USA) and Program Committee Member of EuroPCR. Dr Seth has been invited to lecture at more than 400 national & international meetings and to teach complex angioplasty techniques through Live Demonstration at more than 100 national & international meetings around the world. He has more than 350-publications to his credit in peer reviewed Indian and International medical journals and has chapters in 30-books on Cardiology and has been the Editor of 3-books. He is an acclaimed teacher and has trained more than 500-cardiologists of India and abroad in advanced techniques of angioplasty.
Dr Simon Walsh has been working as a Consultant Cardiologist at the Belfast Trust for over 10 years. It is one of the largest NHS trusts in the UK. The centre performs ~2750 PCI per year, with 650-700 STEMI and calcium modification in ~10% of our PCI cases. Dr Walsh also works internationally as an educator, teaching advanced techniques for complex PCI and CTO PCI. This involves training visiting Cardiologists in Belfast retrograde CTO techniques, antegrade dissection and re-entry CTO techniques and other advanced PCI procedures. He has visited multiple centres in the UK, Ireland, Europe, Australia, Asia and North America to act as a visiting proctor for complex PCI and CTO PCI cases. Dr Walsh’s research interests include PCI, coronary artery disease, defibrillation, acute coronary syndromes and chronic total occlusions. Research responsibilities have included acting as a recruiting investigator for the >25 multicentre studies over the last 17 years. He acted as a primary investigator for numerous international trials including the Evolve, Noble, Leaders Free and Ischemia multicentre studies. He has been the lead UK investigator for the October trial, Syntax 2, Recharge and Ischaemia-CTO. He is also the Chief Investigator for the Consistent CTO, Celtic Bifurcation and Discrete CTO trials.
Dr. Nijjer is a Consultant Cardiologist and Senior Clinical Lecturer at Imperial College London. He works at both the Hammersmith Hospital and Chelsea & Westminster Foundation NHS Trust, as well as leading private Hospitals in London including the Wellington and Cromwell Hospitals. He is the President-elect of the Cardiology Section of the Royal Society of Medicine, and he was selected as an Emerging Leader for the British Cardiovascular Society. He specialises in coronary intervention and focused his clinical practice in the management of ischaemic heart disease. His practice encompasses all aspects of cardiology. In his PhD research, funded by the Medical Research Council (UK) and awarded by Imperial College he developed of new intracoronary physiology techniques, specifically iFR and iFR-pullback and Co-registration. He has published almost 100 peer-reviewed papers in respected journals, including the New England Journal of Medicine and The Lancet. He has also written several books.
Professor Jacek Legutko is an interventional cardiologist with over 25 years of experience in the field. His main research interest is focused on primary PCI in acute myocardial infarction, intravascular imaging and physiology lesion assessment in the cathlab, as well as complex percutaneous coronary interventions (PCI). He has performed a series of studies in those areas and has participated in many clinical trials. Professor Legutko is a Course Director at the New Frontiers in Interventional Cardiology (NFIC), an international congress organized annually in Krakow, Poland since 1999. He has also served as a Faculty member, live case operator and facilitator for several interventional cardiology meetings including EuroPCR, PCR Africa, TCT, C3, CardioEgypt, and WCCI. Professor Legutko received several professional awards, including prestigious “Andreas Award” granted for his personal impute on the development of interventional cardiology in Poland.
Dr. Joo Myung Lee is an interventional cardiologist in Samsung Medical Center, Sungkyunkwan University School of Medicine, Korea. He is an high-volme operator (>400 PCI per year) and has been performed many researched in coronary physiology, intravascular imaging, and non-invasive imaging including N13-ammonium PET and CCTA. He has published several articles in major cardiology journals including JACC, Circulation, and EHJ.
Dr Roberto Garbo is an Interventional Cardiologist in Maria Pia Hospital GVM Care & Research, Turin, Italy. He is a Director of CTO and Complex PCI program, Board member of EuroCTO Club since 2017 and IVUS guided CTO expert in both antegrade and retrograde approach.
Dr Nieves Gonzalo is Consultant Interventional Cardiologist at the Interventional Cardiology Department at Clinico San Carlos University Hospital in Madrid. She obtained her Specialist Certification in Cardiology after training at Clinico San Carlos University Hospital in Madrid. Subsequently, she underwent a research fellowship at Thoraxcenter, Erasmus University Rotterdam (The Netherlands) under the supervision of Professor Patrick Serruys, focused mainly in intracoronary imaging and bioabsorbable stents. In 2010 she obtained her PhD with the thesis “Optical coherence tomography for the assessment of coronary atherosclerosis and vessel response after stent implantation”. Her track record includes over 170 articles indexed in PubMed, as well as book chapters in Interventional Cardiology textbooks. Recent research projects as principal investigator includes a study about the assessment of neoatherosclerosis and its clinical impact in patients with restenosis (RIBS IV and V OCT substudy) and research regarding vessel injury and healing evaluation with different stent platforms evaluated with OCT (VISTA study). Dr Gonzalo is a dedicated educationalist with involvement in many areas of complex PCI, serving currently as Deputy Editor for Eurointervention and Committee Member of EuroPCR.
Dr Hernán Mejía-Rentería is Interventional Cardiologist at Hospital Clinico San Carlos (Madrid, Spain). He graduated from the Medical School of Universidad del Valle (Colombia) and underwent specialty training in Cardiology from 2010 to 2015 at Hospital Clinico San Carlos, Madrid, Spain. Subsequently, he completed his subspecialty training as Interventional Fellow in 2017 at the same institution. He has published numerous indexed scientific articles on coronary physiology, functional angiography, intracoronary imaging techniques and Takotsubo Syndrome, and is author of chapters in different academic textbooks. He participates actively as a reviewer of studies in the peer-review modality in different indexed scientific journals. His main research areas at present include coronary artery disease, functional angiography, intracoronary physiological assessment of ischemic heart disease and microcirculatory dysfunction. He is currently developing his doctoral thesis at the Complutense University of Madrid, focused on physiological assessment of coronary heart disease in different clinical settings.
Works at Nanjing First Hospital,Nanjing Medical University, Nanjing, Jiangsu, China. Features in 4 videos on Wondr Medical. Shao Liang Chen generally speaks on Coronary Interventions, Coronary Optical Coherence Tomography (OCT), Intravascular Ultrasound (IVUS), Bifurcation, and Primary Percutaneous Coronary Intervention (PPCI).
Angela McInerney is an Interventional Cardiology Fellow in Hospital Clínico San Carlos. Her specialist interests are in intracoronary imaging, intracoronary physiology, calcium modification techniques and complex PCI. She underwent her medical training at the National University of Ireland, Galway and graduated in 2011. She undertook her internal medicine training between Galway University Hospital, Merlin Park Hospital and also trained for six months in internal medicine in the Mayo Clinic Rochester, Minnesota. She did her general cardiology training in Ireland working in Beaumont Hospital, St Vincents University Hospital and Cork University Hospital. She was awarded the Brian McGovern Travelling Fellowship grant from the Irish Board for Cardiology Training in 2018 which allowed her to start her interventional fellowship in Hospital Clínico San Carlos. She has been keenly involved in various research projects pertaining to intracoronary physiology and intravascular imaging having authored and co-authored a number of research articles as well as review articles and book chapters. Angela regularly partakes in the preparation and delivery of educational courses in Clínico San Carlos and values the educational aspect of her role. She plans to complete her coronary interventional fellowship before completing a structural intervention fellowship also within Hospital Clínico San Carlos for which she has received a European Cardiology Society grant.
Dr. Evan Shlofmitz is an Interventional Cardiologist and the Director of Intravascular Imaging at St. Francis Hospital - The Heart Center in Roslyn, NY. He completed a fellowship in Interventional Cardiology at Georgetown University/MedStar Washington Hospital Center. He previously completed an Intravascular Imaging and Physiology fellowship at the Cardiovascular Research Foundation (CRF) and Columbia University Medical Center (CUMC), a Cardiovascular Disease fellowship at Northwell Health and served as Chief Resident for Internal Medicine at New York Presbyterian Queens. Dr. Shlofmitz has a strong interest in clinical education and research, lecturing internationally. He is a course director for Optimizing PCI (O-PCI) and CRT's Imaging & Physiology course and serves on SCAI's Ischemic Heart Disease Council and the steering committee for the IMPROVE trial. His research interests have centered on intravascular imaging, the treatment of calcified coronary artery disease, in-stent restenosis and the optimization of stent implantation, with more than 125 publications in peer-reviewed journals.
Dr. Pablo Salinas is Interventional Cardiologist at Hospital Clínico San Carlos in Madrid, Spain. He studied Medicine at Universidad Complutense in Madrid, Spain and was trained in Cardiology and Interventional Cardiology at Hospital La Paz in Madrid, Spain. In 2015 he obtained his PhD degree (cum laude) at the Universidad Autonoma in Madrid. He has developed his professional career in the field of interventional cardiology for over 10 years, and is a skilled operator in complex coronary intervention, chronic occlusions, and stroke prevention therapies such as foramen ovale closure and appendage closure, with regular participation in educational events and live cases. During his research career he has 80+ PubMed indexed publications and is currently the PI of three multicenter studies SUGAR Trial (NCT03321032), REVASEC Registry (NCT03349385), and TROMPA Registry. Also he has been researcher in several investigator initiated, competitive funding research (PI16 / 00840, PIE16 / 00043, PI15 / 00742).
Dr Breda Hennessey is an interventional cardiology fellow at Hospital Clínico San Carlos. She Graduated from the Third Faculty of Medicine in Charles University in Prague. Following this ,she returned to Ireland in 2011. She completed her Internal Medicine training in 2014 and General Cardiology training in 2019 through the Royal College of Physicians in Ireland. She was awarded the Brian McGovern Scholarship by the Irish Cardiac Society in 2019 and commenced her clinical and research fellowship at Hospital Clínico San Carlos last November. She Is currently working as an assistant PI in the ongoing DCR4 contrast study, a multicentred prospective randomised study, investigating the impact of new technologies in reducing contrast burden in complex PCI . She is also involved with the complex PCI subset, including the CTO programme at Hospital Clínico San Carlos.
Dr Richard A. Shlofmitz, MD, FACC is the Chairman of Cardiology at St. Francis Hospital, The Heart Center®, in Roslyn, New York. A pioneer in interventional cardiology, Dr. Shlofmitz has worked to advance the field, with a focus on optimizing outcomes with the development of Precision PCI. He is a founding co-director of the annual Intravascular Imaging and Coronary Physiology Workshop. Performing over 1,000 coronary interventions annually, he has one of the largest volumes of experience in PCI. He has the most clinical experience with orbital atherectomy and OCT world-wide. His clinical research interests focus on optimizing coronary interventions and he serves on multiple scientific advisory boards and clinical trial steering committees to further this mission. Dr Shlofmitz has been one of the largest enrollers for multiple clinical trials, including TWILIGHT, ILUMIEN III, and Onyx, with more than 75 publications in peer-reviewed journals and was first to perform coronary intravascular lithotripsy (IVL) in North America as part of the DISRUPT CAD III trial.
Tommaso Gori is Professor for translational vascular medicine at the University Medical Center of Mainz, Germany where he also leads the Cardiac Catheterization Laboratory and the Clinical Study Center. He obtained his title of Dottore in Medicina e Chirurgia (MD equivalent) from the University of Siena, Italy, and his PhD from the University of Toronto, Canada. He has worked in Siena, Italy, Toronto, Canada and Mainz, Germany. Dr Gori was winner of 19 international awards, among which the American Heart Association – S.A. Levine Young Investigator Award and the Young Investigator Award of the American College of Cardiology, both in the year 2001. Dr Gori has authored 300 peer-reviewed papers in the fields of endothelial (dys)function, mechanisms of action and effects of organic nitrates, physiology of the coronary circulation, oxidative stress, ischemic preconditioning, microcirculation and hemorheology and interventional cardiology (h-index 38). Dr Gori´s areas of clinical expertise include structural, peripheral and coronary interventions and imaging modalities.
Ziad Ali is the Director of the DeMatteis Cardiovascular Institute, Director of Investigational Interventional Cardiology, and Director of Cardio-nephrology at St Francis Hospital & Heart Center in New York. He is also Director of the Angiographic Core Laboratory at Cardiovascular Research Foundation and Associate Professor of Medicine at Columbia University Medical Center. His clinical research interests focus on the use of intravascular imaging and physiology technologies such as optical coherence tomography, intravascular ultrasound, and flow wire assessment to optimize coronary interventions, for which he has served as a Global principal investigator on a number of trials. Dr. Ali is also a recognized innovator, playing an integral role in the development of the Resting Full-Cycle Ratio (RFR) and Shockwave intravascular lithotripsy. Clinically Dr. Ali developed pioneering techniques to perform vascular interventions without contrast administration, including IVUS-guided zero-contrast PCI and OCT using saline flush media, protecting patients with advanced kidney disease from acute kidney injury and the need for dialysis.
Dr. Singh is an Associate Professor of Medicine, Medical Director, Cardiac Catheterization Laboratory at Barnes-Jewish Hospital and Director of Interventional Cardiology. He specializes in coronary and peripheral vascular interventional procedures and spends most of his time in the cardiac catheterization laboratory. His expertise is in complex coronary intervention and also the endovascular treatment of renovascular hypertension, and peripheral arterial occlusive diseases. In addition, he has been involved in research ranging from new coronary devices to intravascular ultrasound and pressure/flow assessment of coronary vessels. He is the Principal Investigator in several high profile multicenter trials evaluating the above. He is actively involved in resident/fellow education and rotate in the coronary care unit twice a year. He has two interventional fellows per year who work closely with him during their training, he also serves as their attending in ½ day in patient clinic. He has second and third year cardiology fellows involved in clinical research protocols in the cath lab and their work has produced three instrumental abstracts/papers which in the first 12 months were presented at major cardiovascular society meetings. Dr. Singh is also the Chairman of ARCH, one of the largest Midwest Interventional Symposium.
Dr Takayuki Warisawa is a Consultant Interventional Cardiologist at St. Marianna University School of Medicine Yokohama City Seibu Hospital in Japan. After graduating with honours from the prestigious University of Tokyo, he concentrated on clinical work, especially in the field of cardiology, emergency medicine, and intensive care. He trained as an interventional cardiologist for five years at New Tokyo Hospital, which is renowned for high-level interventional cardiology and clinical research. There, he developed skill and insight for complex PCI procedure. He had also taken the role of the Director of Emergency Medicine. While working as an expert clinician, he performed many clinical studies focused on the invasive and non-invasive coronary physiology including iFR/FFR, IMR/CFR, Scintigraphy and Perfusion CMR. Many of the studies have been published in international journals and a selection have been awarded at the Japanese scientific congress. Dr Warisawa is very focused and enthusiastic about invasive coronary physiology and is currently collaborating with Dr Justin Davies on several clinical studies, as well as working as a main operator at his cathlabo.
Dr. Kambis Mashayekhi is the Deputy of the Medical Director and the Director for Chronic Total Occlusion (CTO) and Complex Higher-risk and Indicated Procedures (CHIP) at the University Heartcenter Freiburg – Bad Krozingen. He is responsible for over 600 CTO procedures per year performed at his center. In 2013 Dr. Mashayekhi became EuroCTO Club member. Dr. Mashayekhi is actually performing over 350 CTO-PCI’s per year and is an world-renowned CTO and complex PCI specialist. Dr. Mashayekhi is the head of the CTO working group from the German Society of cardiology and the Co-Director of MLCTO and EuroCTO course. He is the new EuroCTO president elect for 2023.
Nicola Ryan is a Consultant Interventional Cardiologist in Aberdeen Royal Infirmary and the University of Aberdeen, Scotland. She received her medical degree from the Royal College of Surgeons in Ireland (2008), followed by Internal Medicine (2011) and Cardiology training (2015) through the Royal College of Physicians in Ireland. Thereafter, she completed a prestigious Interventional Cardiology and research fellowship in Hospital Clínico San Carlos, Madrid (2017). Dr Ryan's interests are primarily in the role of intra-coronary physiology and imaging, which she routinely applies in her clinical practice as well as in the clinical interventional research she leads in Aberdeen. She engages as a reviewer for several high impact journals. Dr Ryan is a member of the EuroPCR Scientific Committee and the PCR NextGen group, as well as a member of the European Society of Cardiology fellowship committee.
An interventional cardiology director at Soroka Medical Center, Ben Gurion University, Israel. Features in 2 videos on Wondr Medical. Carlos Cafri generally speaks on Coronary Interventions, Primary Percutaneous Coronary Intervention (PPCI), and Multi Vessel Disease.
Prof Goran Stankovic is a Professor of Internal Medicine and Cardiology at the Faculty of Medicine, University of Belgrade, Head of the Department of Cardiology, Clinical Center of Serbia and Chief of Invasive Diagnostics and Interventional Cardiology. Prof. Stankovic was awarded Fellow of the European Society of Cardiology (FESC) in 2003, and Fellow of the American College of Cardiology (FACC) in 2005. He has been a member of European Association for Percutaneous Coronary Interventions (EAPCI) since 2007 and is currently a member of the EAPCI Nominating Committee. He has been one of the founding members and is currently the president of the European Bifurcation Club, and a member of the Asian and Indian Bifurcation Clubs. Professor Stankovic serves on the editorial boards of Journal of the American College of Cardiology, Eurointervention, European Journal of Cardiovascular Medicine, Advances in Interventional Cardiology Journal, and Heart and Blood Vessels – Journal of Cardiology Society of Serbia. For the consecutive years 2005-2014 Professor Stankovic was awarded Elite Reviewer for Journal of American college of Cardiology. In 2009 he received Simon Dack Award for outstanding Scholarship from the American College of Cardiology Foundation.
Ranil de Silva is Senior Lecturer in Clinical Cardiology at the National Heart and Lung Institute, Imperial College London and Consultant Interventional Cardiologist at the Royal Brompton Hospital, London, UK. He obtained his medical degree from King’s College London and undertook his PhD in PET imaging at the MRC Cyclotron Unit under Attilio Maseri. His post-doctoral research was at the National Institutes of Health, USA working on MRI guided endovascular intervention and cardiovascular regenerative medicine. His research focuses on imaging to guide the diagnosis, risk stratification and evaluation of novel therapies for patients with acute and chronic coronary syndromes. He leads translational interdisciplinary research programs on coronary atherosclerotic plaque biomechanics evaluated by fluid-structure interaction modelling, post-myocardial infarction left ventricular remodelling using diffusion tensor cardiovascular magnetic resonance, and coronary sinus reducer for treating coronary microvascular dysfunction. He has published more than 100 peer reviewed articles, including Circulation, European Heart Journal, JACC, Nature journals, Lancet and NEJM. He has an h-index 43. He leads the Specialist Angina Service at the Royal Brompton Hospital, which is a nationally recognised service for patients with refractory angina. He is an interventional cardiologist undertaking complex interventional procedures, coronary sinus reduction, LV support and the full range of intracoronary imaging and physiology techniques. He also has an interest in resistant hypertension and has experience in renal denervation.
Prof Ahmed Khashaba, qualified in medicine, specialized in cardiology and interventional cardiology at Egypt’s Ain Shams University Hospitals, and he gained the title of Professor of Cardiology at the same university. He is a member of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and a Fellow of the American Society for Cardiac Angiography and Interventions (SCAI). Having the interest to introduce and employ new technologies, he established the first TAVI program in Egypt in 2011. He was also the first to introduce and perform the following techniques to Egypt: IVUS-VH, OCT, total radial interventions, iFR, MDCT as well as 3D echocardiography. Recently, he performed the first orbital atherectomy in a private hospital in the middle east in UAE. He is also a proctor and trainer for consultants in most of these and other complex cardiac intervention procedures. Prof Khashaba shared as a principal investigator in many of the international multicenter studies in interventional cardiology, including the landmark DEFINE-FLAIR study. He was also the only cardiologist from the middle east to share in the production of the European consensus document for Rotablator usage. He has over 35 publications and over 90 oral presentations as a faculty member and live demonstrator at several national, regional and international cardiology meetings.
Planning and guidance of complex percutaneous coronary interventions
The course will be largely based on live learning from live...
3:00 AM - 3:05 AM America/New_York
With Javier Escaned and Justin Davies
3:05 AM - 4:00 AM America/New_York
With Julian Javier, Justin Davies, Kambis Mashayekhi, and Ashok Seth
4:00 AM - 5:30 AM America/New_York
With Nieves Gonzalo, Javier Escaned, Ahmed Khashaba, and Simon Walsh
Based on a recorded from Hospital Clinico San Carlos, Madrid
Case presenter: Nieves Gonzalo
Discussants: Javier Escaned, Ahmed Kashaba, Simon Walsh
5:30 AM - 6:45 AM America/New_York
Trends in the use of physiology in planning and guiding complex PCI
Speaker: Sukhjinder Nijjer
Contemporary use of imaging for planning and guidance...
9:00 AM - 9:30 AM America/New_York
With Roberto Garbo and Nieves Gonzalo
Imaging techniques in CTO revascularisation
Speaker: Roberto Garbo
Contemporary aspects of planning and performing PCI in heavily calcified vessels...
9:30 AM - 11:00 AM America/New_York
With Javier Escaned, Justin Davies, and Hernán Mejía-Rentería
Why PCI is currently a suboptimal treatment for angina? Javier Escaned
Residual obstructive disease: Justin Davies
Non-obstructive causes: Hernán Mejía-Rentería
3:30 AM - 3:35 AM America/New_York
With Javier Escaned and Justin Davies
3:35 AM - 4:30 AM America/New_York
With Goran Stankovic, Takayuki Warisawa, and Javier Escaned
4:30 AM - 5:30 AM America/New_York
With Angela McInerney, Javier Escaned, Nicola Ryan, and Carlos Cafri
Case presenter: Angela McInnerney
Discussants: Nicola Ryan, Javier Escaned, Carlos Cafri
5:30 AM - 6:00 AM America/New_York
With Evan Shlofmitz and Pablo Salinas
Left main revascularisation and its relation to SYNTAX score
Speaker: Evan Shlofmitz
Secondary revascularisation after failed PCI or CABG
6:00 AM - 7:30 AM America/New_York
With Javier Escaned and Nieves Gonzalo
Discussants: Justin Davies, Breda Hennesey, Richard Shlofmitz, Tomasso Gori
9:00 AM - 10:20 AM America/New_York
With Javier Escaned, Breda Hennessey, Jasvindar Singh, and Ziad Ali
Chairmen: Javier Escaned/ Ziad Ali
A change in mindset - Javier Escaned
Intracoronary IVUS for zero- or ultralow-contrast PCI - Ziad Ali
Dynamic Coronary Roadmapping to spare contrast...
10:20 AM - 10:45 AM America/New_York